TFF2 and pancreatic neoplasm: This leads to downregulation of Sp1/3/4 transcription factor and several pro-angiogenic Sp-regulated genes, including bcl-2, survivin, cyclin D1, VEGF, VEGF receptor, and fatty acid synthase, which may account for the antitumoral effects of metformin in pancreatic tumor growth.